Australia Markets open in 4 hrs 16 mins

Bloomin' Brands, Inc. (BLMN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.65-0.89 (-4.11%)
As of 03:44PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.05
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 330.40
52-week low 317.29
50-day moving average 321.38
200-day moving average 322.33

Share statistics

Avg vol (3-month) 31.91M
Avg vol (10-day) 31.69M
Shares outstanding 589.25M
Implied shares outstanding 6N/A
Float 880.89M
% held by insiders 11.36%
% held by institutions 1110.91%
Shares short (14 Dec 2021) 416.12M
Short ratio (14 Dec 2021) 45.4
Short % of float (14 Dec 2021) 424.35%
Short % of shares outstanding (14 Dec 2021) 418.06%
Shares short (prior month 14 Nov 2021) 415.81M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 324 May 2022
Ex-dividend date 426 Feb 2020
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 26 Dec 2020
Most-recent quarter (mrq)25 Sept 2021


Profit margin 3.62%
Operating margin (ttm)5.78%

Management effectiveness

Return on assets (ttm)4.26%
Return on equity (ttm)162.74%

Income statement

Revenue (ttm)3.89B
Revenue per share (ttm)43.88
Quarterly revenue growth (yoy)31.00%
Gross profit (ttm)381.96M
EBITDA 389.41M
Net income avi to common (ttm)140.64M
Diluted EPS (ttm)1.36
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)76.34M
Total cash per share (mrq)0.87
Total debt (mrq)2.22B
Total debt/equity (mrq)1,336.53
Current ratio (mrq)0.27
Book value per share (mrq)1.81

Cash flow statement

Operating cash flow (ttm)388.12M
Levered free cash flow (ttm)279.49M